Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Oesch

Showing results (441-450 of 476) with videos related to

Pageof 48
Sort By:
Progress in Clinical and Biological Research|January 1, 1990
Control of ultimate mutagenic species by diverse enzymesF Oesch, J Doehmer, T Friedberg, et al.
Archives of Biochemistry and Biophysics|September 29, 1998
Differential enantioselectivity of murine glutathione S-transferase isoenzymes in the glutathione conjugation of trans-3,4-dihydroxy-1, 2-oxy-1,2,3,4-tetrahydrobenzo[c]phenanthrene stereoisomersX Hu, A Seidel, H Frank, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|August 10, 2010
Xenobiotic metabolizing enzyme activities in isolated and cryopreserved human liver parenchymal cellsB Diener, M Traiser, M Arand, et al.
Cancer Research|June 1, 1985
Arene imines, a new class of exceptionally potent mutagens in bacterial and mammalian cellsH Glatt, G Ludewig, K L Platt, et al.
Archives of Toxicology|December 1, 1986
cis- and trans-1,2-diphenylaziridines: induction of xenobiotic-metabolizing enzymes in rat liver and mutagenicity in Salmonella typhimuriumH R Glatt, L W Robertson, M Arand, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 26, 1999
Drug metabolizing capacity of cryopreserved human, rat, and mouse liver parenchymal cells in suspensionP Steinberg, T Fischer, S Kiulies, et al.
Experimental Cell Research|July 17, 1998
Differential modulation of CYP2E1 activity by cAMP-dependent protein kinase upon Ser129 replacementB Oesch-Bartlomowicz, P R Padma, R Becker, et al.
Biochemical Pharmacology|June 15, 1989
Effect of hypolipidemic compounds on lauric acid hydroxylation and phase II enzymesH Thomas, L Schladt, M Knehr, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|December 17, 2009
In vitro mammalian metabolism of the mitosis inhibitor zoxamide and the relationship to its in vitro toxicityF Oesch, M Metzler, E Fabian, et al.
International Journal of Cancer|July 3, 1996
Granulocyte-macrophage-colony-stimulating factor enhances immune responses to melanoma-associated peptides in vivoE Jäger, M Ringhoffer, H P Dienes, et al.
Pageof 48

Showing results (441-450 of 476) with videos related to

Sort By:
Pageof 48
Progress in Clinical and Biological Research|January 1, 1990
Control of ultimate mutagenic species by diverse enzymesF Oesch, J Doehmer, T Friedberg, et al.
Archives of Biochemistry and Biophysics|September 29, 1998
Differential enantioselectivity of murine glutathione S-transferase isoenzymes in the glutathione conjugation of trans-3,4-dihydroxy-1, 2-oxy-1,2,3,4-tetrahydrobenzo[c]phenanthrene stereoisomersX Hu, A Seidel, H Frank, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|August 10, 2010
Xenobiotic metabolizing enzyme activities in isolated and cryopreserved human liver parenchymal cellsB Diener, M Traiser, M Arand, et al.
Cancer Research|June 1, 1985
Arene imines, a new class of exceptionally potent mutagens in bacterial and mammalian cellsH Glatt, G Ludewig, K L Platt, et al.
Archives of Toxicology|December 1, 1986
cis- and trans-1,2-diphenylaziridines: induction of xenobiotic-metabolizing enzymes in rat liver and mutagenicity in Salmonella typhimuriumH R Glatt, L W Robertson, M Arand, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 26, 1999
Drug metabolizing capacity of cryopreserved human, rat, and mouse liver parenchymal cells in suspensionP Steinberg, T Fischer, S Kiulies, et al.
Experimental Cell Research|July 17, 1998
Differential modulation of CYP2E1 activity by cAMP-dependent protein kinase upon Ser129 replacementB Oesch-Bartlomowicz, P R Padma, R Becker, et al.
Biochemical Pharmacology|June 15, 1989
Effect of hypolipidemic compounds on lauric acid hydroxylation and phase II enzymesH Thomas, L Schladt, M Knehr, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|December 17, 2009
In vitro mammalian metabolism of the mitosis inhibitor zoxamide and the relationship to its in vitro toxicityF Oesch, M Metzler, E Fabian, et al.
International Journal of Cancer|July 3, 1996
Granulocyte-macrophage-colony-stimulating factor enhances immune responses to melanoma-associated peptides in vivoE Jäger, M Ringhoffer, H P Dienes, et al.
Pageof 48